Search

Your search keyword '"Frebourg T"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Frebourg T" Remove constraint Author: "Frebourg T" Database Unpaywall Remove constraint Database: Unpaywall
84 results on '"Frebourg T"'

Search Results

1. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

3. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

4. 1007P cfDNA and ctDNA variations are predictive of disease progression to conventional transarterial chemoembolization (cTACE) in patients with hepatocellular carcinoma (HCC)

7. THE LANDSCAPE OF SOMATIC MUTATIONS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, LEG-TYPE

8. Diagnostic performance of liquid biopsy for pancreatic solid lesion as alternative to endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)

9. Prospective analysis of CEA, CA19.9, circulating DNA (cDNA) and circulating tumor cells (CTC) in patients (pts) treated for a metastatic colorectal cancer (mCRC)_Results of COCA-COLON study

10. Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma

13. A Bar Code of Selected Gene Copy Number Alterations is Associated with Disease-Free Survival in Stage Ii-Iii Microsatellite Stable (Mss) Colon Cancer

16. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests

17. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification

18. Different Clinical Outcome of Metastatic Colorectal Cancer (MCRC) Patients Treated with Intensive Triplet Chemotherapy Plus Bevacizumab (FIR-B/FOX) According to Kras Genotype and Disease Extension

21. P2-13-06: Feasibility of Fast-Track Germline Genetic Analyses for Localized Breast Cancer Patients and Its Impact on Local Management.

25. CL088 - Prédisposition génétique au neuroblastome

28. O1-6 Identification par crible génétique dans la drosophile de modulateurs de la neurotoxicité de la protéine Tau et caractérisation neuropathologique de leurs homologues humains

29. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations

31. TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy

36. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene

37. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas

45. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

46. Variations in the APP gene promoter region and risk of Alzheimer disease

47. Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics

48. Phénotype associé à une duplication du gène APP dans 6 familles françaises

Catalog

Books, media, physical & digital resources